NuPathe Nixes Endo Deal, OKs $114M Teva Takeover
Specialty pharmaceuticals company NuPathe Inc. accepted a $114.3 million takeover bid from Israel-based Teva Pharmaceutical Industries Ltd., discarding a December deal to sell itself to Endo Health Solutions Inc. for $105...To view the full article, register now.
Already a subscriber? Click here to view full article